bioAffinity Technologies, Inc. Common Stock, Value, Issued
bioAffinity Technologies, Inc. (BIAF) had Common Stock, Value, Issued of $47.45 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Issued $47.45K.
- 2026-03-31: Common Stock, Value, Issued $31.46K.
- 2025-12-31: Common Stock, Value, Issued $31.46K.
- 2025-09-30: Common Stock, Value, Issued $24.26K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $47.45K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $31.46K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $31.46K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $24.26K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $197.24K 10-Q · filed 2025-08-14 | |
| 2025-05-22 | $5.80M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $124.78K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.55K 10-K · filed 2026-03-16 | $106.59K 10-K · filed 2025-03-31 |
| 2024-09-30 | $90.06K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $79.41K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $78.52K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $65.76K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $64.53K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $59.89K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $59.24K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $58.67K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $58.59K 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $18.74K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |